Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial

Clinical trial NCT05928806 · SUSPENDED

Trial details

NCT number: NCT05928806
Sponsor: Michael B. Atkins, MD
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Renal Cell Carcinoma

Start date: 2023-09-25
Primary completion: 2026-11-10
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.